The Food and Drug Administration this week released final guidance for pharmacies, federal facilities and outsourcing facilities that compound or repackage drugs or mix, dilute or repackage biological products. The guidance provides examples of insanitary conditions under the Federal Food, Drug and Cosmetic Act, and recommended actions to prevent or correct insanitary conditions in compounding facilities.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services July 15 issued a proposed rule that would increase Medicare hospital outpatient prospective payment system…
Headline
AHA May 23 submitted recommendations to the Department of Justice and Federal Trade Commission in response to the agencies’ requests for information on…
Headline
The Department of Health and Human Services May 13 announced a 60-day public comment period opened for stakeholders regarding its request for information to…
Headline
The Centers for Medicare & Medicaid Services today released a notice seeking public comment on the collection of information request regarding the State…
Headline
The Trump administration yesterday released executive orders on reducing anti-competitive regulatory barriers and repealing certain regulations deemed unlawful…
Headline
The Office of Management and Budget April 9 released a notice seeking public input on rules to potentially be rescinded, requesting detailed reasons…